Brydøy M - Search Results

1

Mortality and Second Cancer Incidence After Treatment for Testicular Cancer: Psychosocial Health and Lifestyle Are Modifiable Prognostic Factors.

Fosså SD, Dahl AA, Thorsen L, Hellesnes R, Kiserud CE, Tandstad T, Brydøy M, Haugnes HS, Myklebust TÅ. Fosså SD, et al. Among authors: brydoy m. J Clin Oncol. 2022 Aug 10;40(23):2588-2599. doi: 10.1200/JCO.21.02105. Epub 2022 Apr 5. J Clin Oncol. 2022. PMID: 35380874

2

Paternity following treatment for testicular cancer.

Brydøy M, Fosså SD, Klepp O, Bremnes RM, Wist EA, Wentzel-Larsen T, Dahl O. Brydøy M, et al. J Natl Cancer Inst. 2005 Nov 2;97(21):1580-8. doi: 10.1093/jnci/dji339. J Natl Cancer Inst. 2005. PMID: 16264178

3

The effects of cancer and cancer treatments on male reproductive function.

Magelssen H, Brydøy M, Fosså SD. Magelssen H, et al. Among authors: brydoy m. Nat Clin Pract Urol. 2006 Jun;3(6):312-22. doi: 10.1038/ncpuro0508. Nat Clin Pract Urol. 2006. PMID: 16763643 Review.

4

Gonadal dysfunction and fertility problems in cancer survivors.

Brydøy M, Fosså SD, Dahl O, Bjøro T. Brydøy M, et al. Acta Oncol. 2007;46(4):480-9. doi: 10.1080/02841860601166958. Acta Oncol. 2007. PMID: 17497315 Review.

5

Association between long-term neuro-toxicities in testicular cancer survivors and polymorphisms in glutathione-s-transferase-P1 and -M1, a retrospective cross sectional study.

Oldenburg J, Kraggerud SM, Brydøy M, Cvancarova M, Lothe RA, Fossa SD. Oldenburg J, et al. Among authors: brydoy m. J Transl Med. 2007 Dec 27;5:70. doi: 10.1186/1479-5876-5-70. J Transl Med. 2007. PMID: 18162130 Free PMC article.

6

Pulmonary function in long-term survivors of testicular cancer.

Haugnes HS, Aass N, Fosså SD, Dahl O, Brydøy M, Aasebø U, Wilsgaard T, Bremnes RM. Haugnes HS, et al. Among authors: brydoy m. J Clin Oncol. 2009 Jun 10;27(17):2779-86. doi: 10.1200/JCO.2008.18.5181. Epub 2009 May 4. J Clin Oncol. 2009. PMID: 19414680

7

Observational study of prevalence of long-term Raynaud-like phenomena and neurological side effects in testicular cancer survivors.

Brydøy M, Oldenburg J, Klepp O, Bremnes RM, Wist EA, Wentzel-Larsen T, Hauge ER, Dahl O, Fosså SD. Brydøy M, et al. J Natl Cancer Inst. 2009 Dec 16;101(24):1682-95. doi: 10.1093/jnci/djp413. J Natl Cancer Inst. 2009. PMID: 19940282 Free PMC article.

8

Paternity and testicular function among testicular cancer survivors treated with two to four cycles of cisplatin-based chemotherapy.

Brydøy M, Fosså SD, Klepp O, Bremnes RM, Wist EA, Wentzel-Larsen T, Dahl O; Norwegian Urology Cancer Group III study group. Brydøy M, et al. Eur Urol. 2010 Jul;58(1):134-40. doi: 10.1016/j.eururo.2010.03.041. Epub 2010 Apr 2. Eur Urol. 2010. PMID: 20395037

9

Long-term and late effects of germ cell testicular cancer treatment and implications for follow-up.

Haugnes HS, Bosl GJ, Boer H, Gietema JA, Brydøy M, Oldenburg J, Dahl AA, Bremnes RM, Fosså SD. Haugnes HS, et al. Among authors: brydoy m. J Clin Oncol. 2012 Oct 20;30(30):3752-63. doi: 10.1200/JCO.2012.43.4431. Epub 2012 Sep 24. J Clin Oncol. 2012. PMID: 23008318

10

Sperm counts and endocrinological markers of spermatogenesis in long-term survivors of testicular cancer.

Brydøy M, Fosså SD, Klepp O, Bremnes RM, Wist EA, Bjøro T, Wentzel-Larsen T, Dahl O; Norwegian Urology Cancer Group (NUCG) III study group. Brydøy M, et al. Br J Cancer. 2012 Nov 20;107(11):1833-9. doi: 10.1038/bjc.2012.471. Br J Cancer. 2012. PMID: 23169336 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

31 results

Search Page